Spend $99, get free U.S. shipping*

Tariff now required on U.S. shipments. Learn more »

Tel: 1-866-456-3768 Fax: 1-866-544-8993

What is the correct Xigduo XR dosage when I’m also managing chronic kidney disease?

According to available prescribing information, Xigduo XR is not recommended for patients with moderate to severe chronic kidney disease due to increased risks and reduced effectiveness.

Overview

If you’re managing both type 2 diabetes and chronic kidney disease (CKD), your doctor may need to adjust or avoid certain medications. Xigduo XR combines two blood sugar-lowering agents, but its use in patients with impaired kidney function requires caution. In this guide, we’ll briefly review:

  • How Xigduo XR works to control blood sugar
  • Why kidney function matters when taking this medicine
  • Potential safety risks for patients with CKD
  • How to access the medicine responsibly if prescribed

This helps explain why careful provider decisions are key when CKD is involved.

Detailed Information

How it works

Xigduo XR is a fixed-dose medication that may help lower blood glucose in adults with type 2 diabetes. It combines dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, with metformin extended-release, which reduces glucose production in the liver and improves insulin sensitivity.

Dapagliflozin promotes glucose excretion through urine, an action that directly depends on kidney function, making CKD status essential when evaluating this therapy.

Clinical applications

Xigduo XR is generally used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes. However, it is not approved for use in type 1 diabetes or in patients with significant renal impairment. Prescribers typically determine eligibility based on a patient’s estimated glomerular filtration rate (eGFR).

This highlights the need to evaluate kidney function before starting or adjusting the dosage.

Safety and Effectiveness

Safety profile

According to Drugs.com, Xigduo XR is not recommended in patients with an eGFR below 45 mL/min/1.73 m². In patients with significantly reduced kidney function, use may lead to worsened lactic acidosis risk from metformin or reduced clearance of dapagliflozin. Patients may also experience side effects such as urinary tract infections, dehydration, and increased urination.

FDA approval and indications

Xigduo XR is FDA-approved for improving glycemic control in type 2 diabetes mellitus, but its approval excludes those with marked renal impairment. Routine kidney monitoring is advised during treatment.

If your kidney disease progresses, your healthcare provider may switch you to a more appropriate therapy.

Access and Availability

How to obtain safely

A licensed international pharmacy like IsraelPharm provides access to Xigduo XR at competitive prices for eligible patients. It’s vital to consult your healthcare provider and have your kidney function tested regularly before using this medication.

Key Takeaways

  • Xigduo XR is not recommended for patients with moderate to severe chronic kidney disease.
  • Dapagliflozin’s action depends on healthy kidney filtration capacity.
  • Metformin use in CKD increases the risk of lactic acidosis.
  • Dosing decisions must be based on your healthcare provider’s evaluation of your eGFR.
  • Purchase from a licensed source and only under medical supervision.

FAQ

What eGFR level is too low for Xigduo XR?

According to prescribing information, Xigduo XR should not be started in patients with an eGFR below 45 mL/min/1.73 m² and must be discontinued if kidney function drops persistently below this level.

Is Xigduo XR safe for mild kidney disease?

For patients with mild CKD or reduced eGFR above 45 mL/min/1.73 m², Xigduo XR may still be used cautiously under close supervision. Renal function should be monitored routinely.

Can I adjust Xigduo XR dosage on my own if I have CKD?

No, never adjust your dosage independently. Only your healthcare provider can determine whether Xigduo XR is suitable, and at what dose, based on your kidney function.

Are there safer alternatives to Xigduo XR for CKD patients?

Yes, several diabetes medications are considered safer for patients with kidney impairment. Your provider may suggest other options based on your renal function and overall health plan.

Is Xigduo XR cheaper through IsraelPharm?

IsraelPharm offers international pricing that may be more affordable than local pharmacies. Contact their team to learn about costs or shipping options for your location.

Login

Fast Delivery
Ships from Israel
Secure Payment
Genuine Brands
Pharmacist Oversight
Proudly Israeli
Free Shipping on orders over $99*

Having issues?

Daily from 9am-8pm EST.
IsraelPharm c/o SUBS Ltd. Ha'Uman 5 Bet Shemesh Israel, 9906105

Sign up for $10 off your first order!

Enjoy exclusive deals we only share via email

Sign up for $10 off your first order!

Enjoy exclusive deals we only share via email